DIADIA0.33%
SPYSPY0.11%
QQQQQQ0.18%
Trending
Top trending tickerAMDAMD2.75%
BBBB6.59%
MRVLMRVL11.02%
SOXSSOXS5.42%
INTCINTC7.13%
SOFISOFI1.35%
LFVNLFVN7.19%
PANWPANW3.76%
GMEGME9.56%
BMNRBMNR1.11%
Top trending tickerAMDAMD2.75%
BBBB6.59%
MRVLMRVL11.02%
SOXSSOXS5.42%
INTCINTC7.13%
SOFISOFI1.35%
LFVNLFVN7.19%
PANWPANW3.76%
GMEGME9.56%
BMNRBMNR1.11%
NDRA logo

NDRAENDRA Life Sciences Inc

$5.03
$0.01
(0.20%)
Pre-Market
Updated: 04:25 AM EDT·Prev Close $5.04
Mkt Cap$7.11M
Vol49.00
40

Bearish Sentiment

How do you feel about NDRA?

Feed

News

Sentiment

Fundamentals

Info

News
all
press releases
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported...
Business Wire
News Placeholder
More News
News Placeholder
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS Liver Device Demonstrating MRI-like Accuracy and Reproducibility
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for the early detection and monitoring of steatotic liver disease (SLD), today announced...
Business Wire
News Placeholder
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported...
Business Wire
News Placeholder
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced that...
Business Wire
News Placeholder
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision
ENDRA posts strong TAEUS Liver study data, showing high measurement reliability for MASLD monitoring and boosting its regulatory and commercial outlook.
Zacks
News Placeholder
ENDRAs TAEUS Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for the early detection and monitoring of steatotic liver disease (SLD), today announced...
Business Wire
News Placeholder
ENDRAs TAEUS Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermo-acoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced new...
Business Wire
News Placeholder
ENDRA Feasibility Study Demonstrates TAEUS Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction-associated liver disease...
Business Wire
News Placeholder
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease...
Business Wire
News Placeholder
ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA
ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease (MASLD) and...
Business Wire
<
1
2
...
>
Top Discussions

Advertisement|Remove ads.